Sedation strategies in children with pediatric acute respiratory distress syndrome (PARDS)

Lynne Rosenberg1, Chani Traube1

  • 1Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA.

Insights

Current pediatric acute respiratory distress syndrome (PARDS) sedation strategies shift from deep benzodiazepine use to lighter sedation with agents like dexmedetomidine. Monitoring sedation, analgesia, withdrawal, and delirium is key for better outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Respiratory medicine

Background:

  • Traditional mechanical ventilation in pediatric acute respiratory distress syndrome (PARDS) involved deep sedation using benzodiazepines.
  • Emerging evidence suggests potential harms associated with deep sedation and prolonged benzodiazepine use in critically ill children.

Purpose of the Study:

  • To review the evolving strategies for sedation in mechanically ventilated children with PARDS.
  • To highlight the shift towards lighter sedation and the use of non-benzodiazepine agents.
  • To emphasize comprehensive monitoring for improved patient outcomes.

Main Methods:

  • Literature review of recent studies and clinical guidelines on sedation in PARDS.
  • Analysis of the benefits and risks of different sedating agents.
  • Discussion of multimodal monitoring parameters.

Main Results:

  • Emerging literature supports lighter sedation protocols over deep sedation for PARDS.
  • Dexmedetomidine and other non-benzodiazepine agents show promise in PARDS sedation.
  • Comprehensive monitoring of sedation depth, analgesia, opiate withdrawal, and delirium is crucial.

Conclusions:

  • The optimal sedation strategy for PARDS is shifting towards lighter, more targeted approaches.
  • Non-benzodiazepine sedatives like dexmedetomidine represent a valuable option.
  • Further research is necessary to refine sedation protocols and improve outcomes in pediatric patients with PARDS.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
397
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
473
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
529
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
695
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
921
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
460